Lowering The Lipid Barrier: Enabling Any Scientist To Be A Genomic Medicine Developer

Nanomedicine is a promising treatment strategy to target a range of diseases with limited side effects and complications. Although RNA (ribonucleic acid) molecules are fragile and can degrade quickly, new non-viral gene delivery approaches, such as nanoparticles, have the potential to deliver a range of RNA-based therapeutics and vaccines effectively. Learn how you can fast-track RNA-LNP development and streamline screening with off-the-shelf ionizable lipid mixes as well as utilize these validation strategies using ready-made formulations to generate reproducible and scalable LNPs for lead candidates.